OPPENHEIMER & CO INC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$42,000
-4.5%
13,188
-13.2%
0.00%0.0%
Q2 2020$44,000
+2.3%
15,1880.0%0.00%0.0%
Q1 2020$43,000
-12.2%
15,1880.0%0.00%0.0%
Q4 2019$49,000
+48.5%
15,1880.0%0.00%0.0%
Q3 2019$33,000
-31.2%
15,1880.0%0.00%0.0%
Q2 2019$48,000
-15.8%
15,1880.0%0.00%
-50.0%
Q1 2019$57,000
+29.5%
15,1880.0%0.00%
+100.0%
Q4 2018$44,000
+10.0%
15,1880.0%0.00%0.0%
Q3 2018$40,000
+11.1%
15,1880.0%0.00%0.0%
Q2 2018$36,000
-20.0%
15,1880.0%0.00%0.0%
Q1 2018$45,000
+45.2%
15,188
+32.2%
0.00%0.0%
Q4 2017$31,000
-39.2%
11,488
-24.4%
0.00%0.0%
Q3 2017$51,000
+34.2%
15,1880.0%0.00%0.0%
Q2 2017$38,000
+11.8%
15,1880.0%0.00%0.0%
Q1 2017$34,000
+3.0%
15,188
-3.2%
0.00%0.0%
Q4 2016$33,000
-37.7%
15,6880.0%0.00%
-50.0%
Q3 2016$53,000
+15.2%
15,688
+7.7%
0.00%
+100.0%
Q2 2016$46,000
-11.5%
14,563
+41.3%
0.00%
-50.0%
Q3 2015$52,000
-36.6%
10,310
-6.3%
0.00%0.0%
Q3 2014$82,000
-42.3%
11,000
-25.2%
0.00%
-50.0%
Q2 2014$142,000
+18.3%
14,710
+2.2%
0.00%0.0%
Q1 2014$120,000
-1.6%
14,4000.0%0.00%0.0%
Q4 2013$122,000
-12.2%
14,400
-17.2%
0.00%
-20.0%
Q3 2013$139,000
+3.0%
17,4000.0%0.01%0.0%
Q2 2013$135,00017,4000.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders